Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation (ABUS)

$3.07

Arbutus Biopharma Corporation (ABUS) Share Price Forecast
Currently 11 wall-street analysts regularly analyze the financials of Arbutus Biopharma Corporation on a frequent basis to provide recommendations along with target share price. 11 analysts offering 12-month price forecasts for Arbutus Biopharma Corporation (ABUS) have a share price target of $4.4. This median of share price forecast represents a 43.32% upside from the latest price of $3.07 as on 22.05.24.

Arbutus Biopharma Corporation (ABUS) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Arbutus Biopharma Corporation (ABUS) share price will touch around $4.4 in next 12-months.
Arbutus Biopharma Corporation (ABUS) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Arbutus Biopharma Corporation's share price and its median forecast price. As on 22.05.24, the difference is -38.86%

Arbutus Biopharma Corporation (ABUS): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Arbutus Biopharma Corporation (ABUS) Share Price : Analyst Recommendation
Based on 11 analysts tracking and researching Arbutus Biopharma Corporation (ABUS) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
6
6
6
Outperform
3
3
3
Hold
2
2
2
Underperform
0
0
0
Sell
0
0
0
Arbutus Biopharma Corporation (ABUS) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Arbutus Biopharma Corporation (ABUS) is $4.4, offered by 11 analysts offering 12-month price forecasts.

Arbutus Biopharma Corporation (ABUS) has a maximum of 0.43 upside potential, based on 11 analysts offering 12-month price forecasts.

Based on 11 analysts tracking and researching Arbutus Biopharma Corporation (ABUS), 81.82% have a buy recommendation. Remaining 18.18% have either sell or hold recommendations.

The latest share price of Arbutus Biopharma Corporation (ABUS) is $3.07 as of 22/05/2024.

9 of total 11 analysts offering stock ratings for Arbutus Biopharma Corporation ABUS have recommended buy rating.